Score on the Feasibility Usage Rating Profile. This scale gathers patient reported feasibility of the intervention (e.g., time needed, quality of materials, simplicity of the intervention) to be completed after doing the intervention. This scale has six items; total scores range from 1-6 and a higher scores indicate greater feasibility.
Score on the Acceptability Usage Rating Profile scale which gathers participant ratings of how acceptable the treatment is for targeting binge eating (e.g., how helpful the intervention was, how much they liked it, willingness to do the intervention) to be completed after doing the intervention. This scale has eight items; total scores range from 1-6, a higher score indicates greater acceptability.
Change in score on the BES survey. The BES is a 16-item, self-report survey that assess binge eating. Total scores range from 0 to 46, with higher scores meaning more severe binge eating symptoms (Gormally et al., 1982).
Baseline
Group
Value
95% CI
BESTOW Behavioral Intervention
24.78
± 5.89
Post
Group
Value
95% CI
BESTOW Behavioral Intervention
14.81
± 5.87
1-month follow-up
Group
Value
95% CI
BESTOW Behavioral Intervention
13.24
± 6.64
2-month follow-up
Group
Value
95% CI
BESTOW Behavioral Intervention
13.81
± 9.08
Geriatric Depression Scale Score (Center for Epidemiologic Studies-Depression Scale; CES-D)Secondary· Baseline, 6 weeks (post), 1 month, and 2 month follow-up
The CES-D is a 10-item, self-report survey that assess depressive symptoms. Mean scores range from 0 to 3, with higher scores indicating more depressive symptoms (Lewinsohn et al., 1997).
Baseline
Group
Value
95% CI
BESTOW Behavioral Intervention
1.15
± 0.59
Post
Group
Value
95% CI
BESTOW Behavioral Intervention
0.91
± 0.75
1-month follow-up
Group
Value
95% CI
BESTOW Behavioral Intervention
0.93
± 0.69
2-month follow-up
Group
Value
95% CI
BESTOW Behavioral Intervention
1.00
± 0.81
Sponsor's own description
Twenty women, ages 60 or older, will be consented and enrolled in a single-arm, pilot implementation trial of the age-tailored cognitive-behavioral based BE intervention. Participants will complete assessments at baseline, post-intervention, and at two follow-up timepoints; weekly BE frequency will be collected to monitor progress during the intervention period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Texas Health Science Center at San Antonio
Last refreshed: 7 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05806788.